Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | ECE1 | P42892 | 2/20 | 0.49 |
| ▸ | ITGB2 | P05107 | 2/20 | 0.45 |
| ▸ | ICAM1 | P05362 | 2/20 | 0.45 |
| ▸ | ITGAL | P20701 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 6/20 | 0.43 |
| ▸ | CA1 | P00915 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8352222 | 0.86 | MEN1 (0.43) | MEN1KMT2AECE1ITGB2ICAM1 | |
| SCHEMBL11269717 | 0.85 | MEN1 (0.47) | MEN1KMT2AECE1ITGB2ICAM1 | |
| SCHEMBL5841326 | 0.83 | CA2 (0.58) | MEN1KMT2ACA2CA1CA4 | |
| SCHEMBL7184807 | 0.82 | ECE1 (0.50) | MEN1KMT2AECE1ITGB2ICAM1 | |
| SCHEMBL3510050 | 0.82 | ECE1 (0.50) | MEN1KMT2AECE1ITGB2ICAM1 | |
| SCHEMBL30052291 | 0.82 | ECE1 (0.50) | MEN1KMT2AECE1ITGB2ICAM1 | |
| SCHEMBL3510048 | 0.82 | ECE1 (0.50) | MEN1KMT2AECE1ITGB2ICAM1 | |
| SCHEMBL16401 | 0.82 | ECE1 (0.50) | MEN1KMT2AECE1ITGB2ICAM1 | |
| SCHEMBL21012597 | 0.81 | KMT2A (0.48) | KMT2ACA2CA1ALOX15BLM | |
| SCHEMBL4182303 | 0.80 | ECE1 (0.53) | MEN1KMT2AECE1ITGB2ICAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7749969-B2 | N- or C- terminally modified small peptides | ZEALAND PHARMA A/S (DK) | 2010-07-06 | — | — | US | disclosed |
| US-20070123469-A1 | N- or C- terminally modified small peptides | ZEALAND PHARMA A/S (DK) | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070123469-A1 | N- or C- terminally modified small peptides | PTMS, CYP11A1, CYP3A4 | MEN1 2325/4885KMT2A 4314/4885ECE1 97/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.